Publications by authors named "Prashanth Thevkar Nagesh"

Background And Aims: Alcohol abuse is the most frequent precipitating factor of acute-on-chronic liver failure (ACLF). We aimed at developing an alcohol-induced ACLF model and dissecting its underlying molecular mechanisms.

Methods: ACLF was triggered by a single alcohol binge (5g/Kg) in a bile duct ligation (BDL) liver fibrosis murine model.

View Article and Find Full Text PDF
Article Synopsis
  • Severe alcohol-associated hepatitis (AH) is a serious liver disease characterized by increased neutrophil infiltration, but the impact of alcohol on neutrophil function is still not fully understood.
  • Researchers discovered that Bruton's tyrosine kinase (BTK) is elevated in neutrophils of AH patients and is activated by alcohol through TLR4 signaling, linked to liver damage.
  • In mouse models, inhibiting BTK or knocking it out in specific immune cells reduced neutrophil activity and damage to the liver, suggesting that targeting BTK and its interaction with CD84 might offer new treatments for AH.
View Article and Find Full Text PDF

Background And Aims: In a recent trial, patients with severe alcohol-associated hepatitis treated with anakinra plus zinc (A+Z) had lower survival and higher acute kidney injury (AKI) rates versus prednisone (PRED). We characterize the clinical factors and potential mechanisms associated with AKI development in that trial.

Approach And Results: Data from 147 participants in a multicenter randomized clinical trial (74 A+Z, 73 PRED) were analyzed.

View Article and Find Full Text PDF

Binge drinking in obese patients positively correlates with accelerated liver damage and liver-related death. However, the underlying mechanism and the effect of alcohol use on the progression of metabolic-dysfunction-associated steatotic liver disease (MASLD) remain unexplored. Here, we show that short-term feeding of a metabolic-dysfunction-associated steatohepatitis (MASH) diet plus daily acute alcohol binges for three days induce liver injury and activation of the NLRP3 inflammasome.

View Article and Find Full Text PDF

Objective: Alcohol use in metabolic dysfunction-associated steatohepatitis (MASH) is associated with an increased risk of fibrosis and liver-related death. Here, we aimed to identify a mechanism through which repeated alcohol binges exacerbate liver injury in a high fat-cholesterol-sugar diet (MASH diet)-induced model of MASH.

Design: C57BL/6 mice received either chow or the MASH diet for 3 months with or without weekly alcohol binges.

View Article and Find Full Text PDF

Granulocyte colony-stimulating factor (G-CSF) has been proposed as a therapeutic option for patients with ACLF, however clinical outcomes are controversial. We aimed at dissecting the role of G-CSF in an alcohol-induced murine model of ACLF. : ACLF was triggered by a single alcohol binge (5 g/kg) in a bile duct ligation (BDL) liver fibrosis model.

View Article and Find Full Text PDF

Background: Cholesterol-loading of mouse aortic vascular smooth muscle cells (mVSMCs) downregulates , a master regulator of the contractile state downstream of TGFβ signaling. this results in transitioning from a contractile mVSMC to a macrophage-like state. This process likely occurs based on studies in mouse and human atherosclerotic plaques.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic liver injury from cholestasis leads to significant tissue damage, fibrosis, and kidney complications; IRF3 plays a key role in regulating inflammation and cell death in this process.
  • In studies with patients and mice models of cholestasis, increased phosphorylation of IRF3 was linked to higher tissue damage in the liver and kidneys, while IRF3 knockout mice showed reduced damage and inflammation.
  • The study highlights a potential mechanism where bile acids activate IRF3, which then upregulates ZBP1, suggesting that the IRF3-ZBP1 pathway could be crucial in understanding and addressing cholestatic liver and kidney injuries.
View Article and Find Full Text PDF

Most chronic liver diseases progress to liver fibrosis, which, when left untreated, can lead to cirrhosis and hepatocellular carcinoma. MicroRNA (miRNA)-targeted therapeutics have become attractive approaches to treat diseases. In this study, we investigated the therapeutic effect of miR-155 inhibition in the bile duct ligation (BDL) mouse model of liver fibrosis and evaluated the role of miR-155 in chronic liver fibrosis using miR-155-deficient (miR-155 knockout [KO]) mice.

View Article and Find Full Text PDF

Acyl-CoA synthetase 1 (ACSL1) is an enzyme that converts fatty acids to acyl-CoA-derivatives for lipid catabolism and lipid synthesis in general and can provide substrates for the production of mediators of inflammation in monocytes and macrophages. Acsl1 expression is increased by hyperglycemia and inflammatory stimuli in monocytes and macrophages, and promotes the pro-atherosclerotic effects of diabetes in mice. Yet, surprisingly little is known about the mechanisms underlying Acsl1 transcriptional regulation.

View Article and Find Full Text PDF

Background & Aims: Pharmacological activation of farnesoid X receptor (FXR) ameliorates liver injury, steatosis and inflammation in mouse models of alcoholic liver disease (ALD), but the underlying mechanisms of the protective effect of FXR against ALD remain unclear.

Methods: To investigate the role of FXR in ALD, we used the NIAAA model of chronic plus binge ethanol feeding in FXR-deficient knockout (FXR KO) mice.

Results: Ethanol-mediated liver injury and steatosis were increased in FXR KO mice, while both WT and FXR KO mice consumed the same amount of alcohol.

View Article and Find Full Text PDF

Myocardial fibrosis is a well-established cause of increased myocardial stiffness and subsequent diastolic dysfunction in the diabetic heart. The molecular regulators that drive the process of fibrotic events in the diabetic heart are still unknown. We determined the role of the microRNA (miR)-15 family in fibrotic remodelling of the diabetic heart.

View Article and Find Full Text PDF

Unlabelled: Viruses dysregulate the host factors that inhibit virus infection. Here, we demonstrate that human enzyme, histone deacetylase 1 (HDAC1) is a new class of host factor that inhibits influenza A virus (IAV) infection, and IAV dysregulates HDAC1 to efficiently replicate in epithelial cells. A time-dependent decrease in HDAC1 polypeptide level was observed in IAV-infected cells, reducing to <50% by 24 h of infection.

View Article and Find Full Text PDF